طراحی وب سایت

frustrated finnish dairy and ingredients firm valio says the european food safety authority (efsa) rejection of its probiotic claim contradicted or ignored peer reviewed data in its dossier that included 86 studies. efsa has rejected immunity claims made on products like lgg-containing gefilus in what may be the most contentious rejection yet, efsa’s health claims panel refused valio’s gut health dossier based on the lactobacillus rhamnosus gg (lgg) strain that included 45 human studies and 41 non-human studies for failing to demonstrate causality.

the european food safety authority has rejected an article 13.5 health claim that sought to link consumption of the probiotic strain, lactobacillus rhamnosus g g, with gastrointestinal benefits. efsa ha rejected a valio probiotic gut health claim finnish dairy and ingredients group valio submitted 45 human studies and 41 non-human studies in its dossier for a claim that the strain could help, “to maintain defence against intestinal pathogens”.

the european food safety authority (efsa) has rejected an article 13.5 claim that sought to link a probiotic cheese called harmony with heart health benefits. efsa rejects 38-publication strong dossier for probiotic heart health cheese efsa’s panel on dietetic products, nutrition and allergies (nda) found estonian firm piimandusühistu e-piim’s dossier that contained 38 publications did not substantiate the proposed claim that read: “regular consumption (at least 3 weeks) of 50 g/day südamejuust (heart cheese) of harmony brand comprising probiotic lactobacillus plantarum tensia helps to maintain the cardio-vascular system/heart health through reduction of blood pressure.

the european food safety authority (efsa) has repeatedly emphasised that the 2006 eu nutrition and health claims regulation is a learning experience for everyone involved – from its health claims assessment panel to industry stakeholders, to the member states and the european commission. that may be so, but it is a highly expensive learning process, with the greatest burden of cost being borne by industry players like danone, the company’s vice president of research and development in its dairy division, frederic rené, said after efsa’s gut/immune function meeting in amsterdam last week.

finnish dairy and ingredients supplier valio is planning to expand the reach of its probiotic juice gefilus as interest in the sector intensifies. gefilus going global? the company confirmed it will soon expand the lactobacillus rhamnosus gg-fortified product beyond the scandinavian markets it has thus far concentrated on. “it’s clear that suddenly there’s a lot going on in this field,” kalle leporanta, export manager at valio dairy innovative concepts and technologies told new nutrition business.

the european food safety authority (efsa) has repeatedly emphasised that the 2006 eu nutrition and health claims regulation is a learning experience for everyone involved – from its health claims assessment panel to industry stakeholders, to the member states and the european commission. that may be so, but it is a highly expensive learning process, with the greatest burden of cost being borne by industry players like danone, the company’s vice president of research and development in its dairy division, frederic rené, said after efsa’s gut/immune function meeting in amsterdam last week.

probi says its business will not be affected by a recent european food safety authority (efsa) ruling that there is not enough evidence linking a proprietary probiotic strain to a decrease in potentially harmful pathogens in the gut. efsa’s panel on dietetic products, nutrition and allergies (nda) looked at health claims related to lactocacillus plantarum 299 (dsm 6595, 67b).

japanese dairy firm yakult has said it will continue to conduct human studies to back-up the health benefits of its probiotic products, after the european food safety authority (efsa) cast doubt on health claims for probiotics. in a series of opinions published on tuesday, efsa assessed more than 800 health claims from food companies. the claims included assertions that probiotic bacteria strains boost the immune system and reduce gut problems.

the uk broadcast committee of advertising practice (bcap) has revised its guidelines to bring them in line with the 2006 european union nutrition and health claims regulation (nhcr). all broadcasts will now be governed by the regulation with groups like the advertising standards authority (asa) acting as watchdog. already stricter interpretation of the link between marketing and science has been apparent in some asa rulings including one against danone for children's immunity health claims it was making in tv adverts for its probiotic drinking yoghurt, actimel.